COMMUNIQUÉ DE PRESSE publié le 02/02/2026 à 14:35, il y a 8 mois 17 jours Newmark Engaged by Vornado Realty Trust for Next Phase of THE PENN DISTRICT Retail Renaissance Newmark Group, Inc. named exclusive leasing agent for retail transformation in THE PENN DISTRICT by Vornado Realty Trust. Newmark to work on Moynihan Retail Corridor with diverse dining options Retail Transformation Newmark Group Vornado Realty Trust THE PENN DISTRICT Moynihan Retail Corridor
COMMUNIQUÉ DE PRESSE publié le 02/02/2026 à 14:30, il y a 8 mois 17 jours With fast charging of EVs up to 300 kW, Baden-Württemberg police strengthens operational readiness Baden-Württemberg police launches pilot project using ADS-TEC Energy's fast charging system for EVs up to 300 kW, ensuring operational readiness at Pforzheim motorway police station ADS-TEC Energy EV Charging Operational Readiness Baden-Württemberg Police Fast Charging System
COMMUNIQUÉ DE PRESSE publié le 02/02/2026 à 14:30, il y a 8 mois 17 jours Unusual Machines Promotes Drew Camden to President Unusual Machines promotes Drew Camden to President, expanding his role in U.S. manufacturing operations. Company focuses on growth and execution to meet increasing demand Growth Manufacturing Operations Unusual Machines Drew Camden Execution
COMMUNIQUÉ DE PRESSE publié le 02/02/2026 à 14:30, il y a 8 mois 17 jours Predictiv AI Provides Pilot Update from Innovate Calgary's Soaring Higher Challenge with Calgary Airports and WestJet Predictiv AI Inc. provides market update on its Shift AI platform success in Soaring Higher Challenge with Calgary International Airport and WestJet, demonstrating real-world operational impact Predictiv AI Inc. WestJet Shift AI Platform Soaring Higher Challenge Calgary International Airport
COMMUNIQUÉ DE PRESSE publié le 02/02/2026 à 14:30, il y a 8 mois 17 jours NanoViricides President Dr. Diwan Interviewed by Mission Matters' Adam Torres NanoViricides, Inc. announces President Dr. Anil R. Diwan's interview on Mission Matters Podcast discussing revolutionary antiviral drugs development and NV-387 efficacy against various viruses NV-387 Antiviral Drugs NanoViricides Inc. Dr. Anil R. Diwan Mission Matters Podcast
COMMUNIQUÉ DE PRESSE publié le 02/02/2026 à 14:00, il y a 8 mois 17 jours Paymetrex Launches Patent Licensing Program to Monetize Mobile Payments IP Portfolio Datametrex AI Limited's subsidiary, Paymetrex Payment Solutions Inc., launches patent licensing program for mobile payments intellectual property with mature portfolio. Strategic partnerships aim to accelerate adoption in complex payments ecosystem Strategic Partnerships Datametrex AI Limited Mobile Payments Paymetrex Patent Licensing Program
COMMUNIQUÉ DE PRESSE publié le 02/02/2026 à 13:57, il y a 8 mois 17 jours Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL Sartorius Stedim Biotech SA déclare le nombre d'actions et de droits de vote composant son capital social. Informations au 31 janvier 2026 Déclaration Droits De Vote Capital Social Sartorius Stedim Biotech Aubagne
COMMUNIQUÉ DE PRESSE publié le 02/02/2026 à 13:57, il y a 8 mois 17 jours Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech S.A. declares the number of shares and voting rights. Details include total shares, theoretical voting rights, and net voting rights Voting Rights Capital Shares Sartorius Stedim Biotech France
COMMUNIQUÉ DE PRESSE publié le 02/02/2026 à 13:56, il y a 8 mois 17 jours Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL Déclaration du nombre d'actions et de droits de vote de Sartorius Stedim Biotech SA, conformément à la réglementation financière Déclaration Droits De Vote Capital Social Réglementation Sartorius Stedim Biotech SA
COMMUNIQUÉ DE PRESSE publié le 02/02/2026 à 13:56, il y a 8 mois 17 jours Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights comprising the issued capital, as of Jan 31, 2026 Voting Rights Shares Sartorius Stedim Biotech Regulatory Announcement Issued Capital
Publié le 19/10/2026 à 19:00, il y a 12 heures 24 minutes COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 : Compte rendu et résultat des votes - Évolution de la gouvernance
Publié le 19/10/2026 à 18:40, il y a 12 heures 43 minutes Reporting on share buyback transactions carried out between October 12 and October 13, 2026
Publié le 19/10/2026 à 18:40, il y a 12 heures 43 minutes Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain les 12 et 13 octobre 2026
Publié le 19/10/2026 à 18:00, il y a 13 heures 24 minutes WHO Grants Emergency Use Listing for BIOFIRE® Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response
Publié le 19/10/2026 à 18:00, il y a 13 heures 24 minutes L’OMS accorde une autorisation d’utilisation d’urgence au test BIOFIRE® Global Fever Special Pathogens, élargissant l’accès au diagnostic différentiel face à l’épidémie d’Ebola
Publié le 19/10/2026 à 23:20, il y a 8 heures 4 minutes CoTec Holdings Corp. Announces Investor Awareness Agreements
Publié le 19/10/2026 à 23:00, il y a 8 heures 24 minutes Eskay Mining Corp. Announces Results of Annual Meeting
Publié le 19/10/2026 à 22:50, il y a 8 heures 34 minutes Bluesky Digital Announces Termination of ChessGold Inc. Transaction and Management and Director Changes
Publié le 19/10/2026 à 22:01, il y a 9 heures 23 minutes Unusual Machines Completes Acquisition of Upgrade Energy, Expanding U.S. Drone Battery Manufacturing
Publié le 20/10/2026 à 07:15, il y a 8 minutes Blue Cap AG: Preliminary Figures for the first half of 2026
Publié le 20/10/2026 à 07:00, il y a 23 minutes INFICON to Publish its Third Quarter 2026 Results on Tuesday, October 27, 2026
Publié le 20/10/2026 à 07:00, il y a 23 minutes BioVersys announces publication of BV100 lung penetration and drug interaction data in two leading peer-reviewed antimicrobial journals